HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Clarins

This article was originally published in The Rose Sheet

Executive Summary

Fragrance sales increased 11.1% to $54.5 mil. (374.2 mil FFr) in the first quarter, the company announces. Clarins skin care sales were up 7.5% to $104.9 mil. (720.2 mil FFr) and the makeup business grew 9.7% to sales of $21.3 mil. (146.5 mil. FFr) over the previous quarter. Consolidated beauty care sales of $182.4 mil., a 21% increase, were reported April 6 (1"The Rose Sheet" April 10, In Brief)

You may also be interested in...



Clarins

Cosmetics sales climbed 21% to $182.4 mil. (1.24 bil. FFr) and consolidated sales were up 18.2% to $196.2 mil. (1.33 bil. FFr) in the first quarter, the company reports April 6. In light of recent consolidation and the firm's "organic growth," Clarins expects net sales to exceed $735.3 mil. (5 bil. FFr) and net profit to jump by more than 10% in 2000. Separately, Serge Rosinoer announces his resignation as president of the management board April 7

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle
UsernamePublicRestriction

Register

RS007894

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel